{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:47:58Z","timestamp":1792842478458,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1038\/ncpuro0211","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T10:30:52Z","timestamp":1119868252000},"page":"282-290","source":"Crossref","is-referenced-by-count":47,"title":["Therapy Insight: sexual and bladder dysfunction associated with diabetes mellitus"],"prefix":"10.1038","volume":"2","author":[{"given":"Domenico","family":"Fedele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpuro0211_CR1","doi-asserted-by":"crossref","unstructured":"The DECODE Study Group (2003) Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26: 61\u201369","DOI":"10.2337\/diacare.26.1.61"},{"key":"BFncpuro0211_CR2","unstructured":"International Diabetes Federation (2000) Diabetes Atlas 2000. Brussels: IDF"},{"key":"BFncpuro0211_CR3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","volume":"414","author":"P Zimmet","year":"2001","unstructured":"Zimmet P et al. (2001) Global and social implications of the diabetes epidemic. Nature 414: 782\u2013787","journal-title":"Nature"},{"key":"BFncpuro0211_CR4","unstructured":"NIH Consensus Conference (1993) Impotence. NIH Consensus Development Panel on Impotence JAMA 270: 83\u201390"},{"key":"BFncpuro0211_CR5","volume-title":"Sexual behaviour in the human male","author":"AC Kinsey","year":"1948","unstructured":"Kinsey AC et al. (1948) Sexual behaviour in the human male. Philadelphia: WB Saunders"},{"key":"BFncpuro0211_CR6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","volume":"151","author":"HA Feldman","year":"1994","unstructured":"Feldman HA et al. (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging study. J Urol 151: 54\u201361","journal-title":"J Urol"},{"key":"BFncpuro0211_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000020098","volume":"37","author":"F Parazzini","year":"2000","unstructured":"Parazzini F et al. (2000) Frequency and determinants of erectile dysfunction in Italy. Eur J Urol 37: 43\u201349.","journal-title":"Eur J Urol"},{"key":"BFncpuro0211_CR8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-4295(02)02102-7","volume":"61","author":"A Nicolosi","year":"2003","unstructured":"Nicolosi A et al. (2003) Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 61: 201\u2013206","journal-title":"Urology"},{"key":"BFncpuro0211_CR9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1185\/030079904125003467","volume":"20","author":"RC Rosen","year":"2004","unstructured":"Rosen RC et al. (2004) The multinational Men's Attitudes to Life Events and Sexuality (MALES) study I: Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 20: 607\u2013617","journal-title":"Curr Med Res Opin"},{"key":"BFncpuro0211_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.eururo.2004.08.017","volume":"47","author":"A Ponholzer","year":"2005","unstructured":"Ponholzer A et al. (2005) Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 47: 80\u201386","journal-title":"Eur Urol"},{"key":"BFncpuro0211_CR11","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2337\/diacare.21.11.1973","volume":"21","author":"D Fedele","year":"1998","unstructured":"Fedele D et al. (1998) Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 21: 1973\u20131977","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/intjepid\/29.3.524","volume":"29","author":"D Fedele","year":"2000","unstructured":"Fedele D et al. (2000) Erectile dysfunction in type 1 and type 2 diabetics in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 29: 524\u2013531","journal-title":"Int J Epidemiol"},{"key":"BFncpuro0211_CR13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1464-410x.2001.02260.x","volume":"88","author":"K Sairam","year":"2001","unstructured":"Sairam K et al. (2001) Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. BJU Int 88: 68\u201371","journal-title":"BJU Int"},{"key":"BFncpuro0211_CR14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000049805","volume":"40","author":"A Bortolotti","year":"2001","unstructured":"Bortolotti A et al. (2001) Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur Urol 40: 392\u2013397","journal-title":"Eur Urol"},{"key":"BFncpuro0211_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2004.06.005","volume":"46","author":"AI El-Sakka","year":"2004","unstructured":"El-Sakka AI (2004) Efficacy of sildenafil citrate in treatment of erectile dysfunction: effect of type 2 diabetes. Eur Urol 46: 503\u2013509","journal-title":"Eur Urol"},{"key":"BFncpuro0211_CR16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","volume":"163","author":"CB Johannes","year":"2000","unstructured":"Johannes CB et al. (2000) Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results of the Massachusetts Male Aging Study J Urol 163: 460\u2013463","journal-title":"J Urol"},{"key":"BFncpuro0211_CR17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0090-4295(02)02158-1","volume":"61","author":"ED Moreira Jr","year":"2003","unstructured":"Moreira ED Jr et al. (2003) Incidence of erectile dysfunction in men 40 to 69 years old: results from a population-based cohort study in Brazil. Urology 61: 431\u2013436","journal-title":"Urology"},{"key":"BFncpuro0211_CR18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0022-5347(05)65771-0","volume":"166","author":"D Fedele","year":"2001","unstructured":"Fedele D et al. (2001) Incidence of erectile dysfunction in Italian men with diabetes. J Urol 166: 1368\u20131371","journal-title":"J Urol"},{"key":"BFncpuro0211_CR19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.326.7386.424","volume":"326","author":"JA Kaye","year":"2003","unstructured":"Kaye JA and Jick H (2003) Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients. BMJ 326: 424\u2013425","journal-title":"BMJ"},{"key":"BFncpuro0211_CR20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM198904203201601","volume":"320","author":"I Saenz de Tejada","year":"1989","unstructured":"Saenz de Tejada I et al. (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. New Engl J Med 320: 1025\u20131030","journal-title":"New Engl J Med"},{"key":"BFncpuro0211_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1464-410x.2001.00067.x","volume":"87","author":"JJ Cartledge","year":"2001","unstructured":"Cartledge JJ et al. (2001) Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int 87: 402\u2013407","journal-title":"BJU Int"},{"key":"BFncpuro0211_CR22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bbrc.2003.11.034","volume":"312","author":"J Angulo","year":"2003","unstructured":"Angulo J et al. (2003) Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 312: 1202\u20131208","journal-title":"Biochem Biophys Res Commun"},{"key":"BFncpuro0211_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1191\/1358863x02vm429ra","volume":"7","author":"R Maas","year":"2002","unstructured":"Maas R et al. (2002) The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 7: 213\u2013225","journal-title":"Vasc Med"},{"key":"BFncpuro0211_CR24","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/01.ju.0000077448.31995.99","volume":"170","author":"RA Costabile","year":"2003","unstructured":"Costabile RA (2003) Optimizing treatment for diabetes mellitus induced erectile dysfunction. J Urol 170 (Pt 2): S35\u2013S39","journal-title":"J Urol"},{"key":"BFncpuro0211_CR25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh R et al. (2001) Advanced glycation end-products: a review. Diabetologia 44: 129\u2013146","journal-title":"Diabetologia"},{"key":"BFncpuro0211_CR26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/diacare.19.3.257","volume":"19","author":"D Giugliano","year":"1996","unstructured":"Giugliano D et al. (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257\u2013267","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","volume":"47","author":"D Koya","year":"1998","unstructured":"Koya D and King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859\u2013866","journal-title":"Diabetes"},{"key":"BFncpuro0211_CR28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813\u2013820","journal-title":"Nature"},{"key":"BFncpuro0211_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1743-6109.2005.20228_1.x","volume":"2","author":"TJ Bivalacqua","year":"2005","unstructured":"Bivalacqua TJ et al. (2005) Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2: 187\u2013198","journal-title":"J Sex Med"},{"key":"BFncpuro0211_CR30","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","volume":"89","author":"S Dhindsa","year":"2004","unstructured":"Dhindsa S et al. (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89: 5462\u20135468","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpuro0211_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC et al. (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11: 319\u2013326","journal-title":"Int J Impot Res"},{"key":"BFncpuro0211_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(01)00008-2","volume":"41","author":"E Wespes","year":"2002","unstructured":"Wespes E et al. (2002) Guidelines on erectile dysfunction. Eur Urol 41: 1\u20135","journal-title":"Eur Urol"},{"key":"BFncpuro0211_CR33","first-page":"6","volume":"1","author":"TF Lue","year":"2004","unstructured":"Lue TF et al. (2004) Summary of the recommendations on sexual dysfunctions in men. J Sex Med 1: 6\u201323","journal-title":"J Sex Med"},{"key":"BFncpuro0211_CR34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","volume":"281","author":"MS Rendell","year":"1999","unstructured":"Rendell MS et al. (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 281: 421\u2013426","journal-title":"JAMA"},{"key":"BFncpuro0211_CR35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","volume":"26","author":"Goldstein","year":"2003","unstructured":"Goldstein et al. (2003) Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind-placebo-controlled fixed dose study. Diabetes Care 26: 777\u2013783","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR36","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/diacare.25.12.2159","volume":"25","author":"I Saenz de Tejada","year":"2002","unstructured":"Saenz de Tejada I et al. (2002) Effects of Tadalafil on Erectile Dysfunction in men with diabetes. Diabetes Care 25: 2159\u20132164","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diacare.20.5.836","volume":"20","author":"D Fedele","year":"1997","unstructured":"Fedele D et al. (1997) A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee Diabetes Care 20: 836\u2013843","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-5347(17)44344-8","volume":"137","author":"R Virag","year":"1987","unstructured":"Virag R and Adaikan PG (1987) Effects of prostaglandin E1 on penile erection and erectile failure. J Urol 137: 1010\u20131017","journal-title":"J Urol"},{"key":"BFncpuro0211_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","volume":"336","author":"H Padma-Nathan","year":"1997","unstructured":"Padma-Nathan H et al. (1997) Treatment of men with erectile dysfunction with transurethral alprostatil. Medicated Urethral System for Erection (MUSE) Study Group. New Engl J Med 336: 1\u20137","journal-title":"New Engl J Med"},{"key":"BFncpuro0211_CR40","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI et al. (2003) Diabetic autonomic neuropathy. Diabetes Care 26: 1553\u20131579","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1464-410X.2005.05392.x","volume":"95","author":"N Yoshimura","year":"2005","unstructured":"Yoshimura N et al. (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95: 733\u2013738","journal-title":"BJU Int"},{"key":"BFncpuro0211_CR42","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.15.12.1835","volume":"15","author":"M Brownlee","year":"1992","unstructured":"Brownlee M (1992) Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15: 1835\u20131843","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0022-5347(05)64636-8","volume":"168","author":"K Sasaki","year":"2002","unstructured":"Sasaki K et al. (2002) Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root ganglia. J Urol 168: 1259\u20131264","journal-title":"J Urol"},{"key":"BFncpuro0211_CR44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dmrr.385","volume":"19","author":"DP Poladia","year":"2003","unstructured":"Poladia DP and Bauer JA (2003) Early cell-specific changes in nitric oxide synthases, reactive nitrogen species formation, and ubiquitinylation during diabetes-related bladder remodeling. Diabetes Metab Res Rev 19: 313\u2013319","journal-title":"Diabetes Metab Res Rev"},{"key":"BFncpuro0211_CR45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.urology.2004.06.021","volume":"64","author":"E Beshay","year":"2004","unstructured":"Beshay E and Carrier S (2004) Oxidative stress pays a role in diabetes-induced bladder dysfunction in a rat model. Urology 64: 1062\u20131067","journal-title":"Urology"},{"key":"BFncpuro0211_CR46","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1523\/JNEUROSCI.21-15-05670.2001","volume":"21","author":"M Vlaskovska","year":"2001","unstructured":"Vlaskovska M et al. (2001) P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 21: 5670\u20135677","journal-title":"J Neurosci"},{"key":"BFncpuro0211_CR47","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1523\/JNEUROSCI.22-18-08063.2002","volume":"22","author":"LA Birder","year":"2002","unstructured":"Birder LA et al. (2002) Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 22: 8063\u20138070","journal-title":"J Neurosci"},{"key":"BFncpuro0211_CR48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s005920200008","volume":"39","author":"DA Pitre","year":"2002","unstructured":"Pitre DA et al. (2002) Time-dependent urinary bladder remodeling in the streptozotocin-induced diabetic rat model;. Acta Diabetol 39: 23\u201327","journal-title":"Acta Diabetol"},{"key":"BFncpuro0211_CR49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005392-199502000-00013","volume":"153","author":"SA Kaplan","year":"1995","unstructured":"Kaplan SA et al. (1995) Urodynamic findings in patients with diabetic cystopathy. J Urol 153: 342\u2013344","journal-title":"J Urol"},{"key":"BFncpuro0211_CR50","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0022-5347(01)66074-9","volume":"155","author":"V Menendez","year":"1996","unstructured":"Menendez V et al. (1996) Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease. J Urol 155: 2001\u20132004","journal-title":"J Urol"},{"key":"BFncpuro0211_CR51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/diacare.28.1.177","volume":"28","author":"J Brown","year":"2005","unstructured":"Brown J et al. (2005) Urologic complications of diabetes. Diabetes Care 28: 177\u2013185","journal-title":"Diabetes Care"},{"key":"BFncpuro0211_CR52","first-page":"310","volume":"11","author":"S Hunskaar","year":"2000","unstructured":"Hunskaar S et al. (2000) Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 11: 310\u2013319","journal-title":"J Pelvic Floor Dysfunct"},{"key":"BFncpuro0211_CR53","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1067\/mob.2003.353","volume":"188","author":"J Brown","year":"2003","unstructured":"Brown J et al. (2003) Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 188: S77\u2013S88","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpuro0211_CR54","first-page":"66","volume":"94","author":"J Brown","year":"1999","unstructured":"Brown J et al. (1999) Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen\/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 94: 66\u201370","journal-title":"Obstet Gynecol"},{"key":"BFncpuro0211_CR55","first-page":"1230","volume":"100","author":"CM Sampselle","year":"2002","unstructured":"Sampselle CM et al. (2002) Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol 100: 1230\u20131238","journal-title":"Obstet Gynecol"},{"key":"BFncpuro0211_CR56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.AOG.0000133482.20685.d1","volume":"104","author":"RA Jackson","year":"2004","unstructured":"Jackson RA et al. (2004) Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol 104: 301\u2013307","journal-title":"Obstet Gynecol"},{"key":"BFncpuro0211_CR57","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2105\/AJPH.89.11.1745","volume":"89","author":"BE Klein","year":"1999","unstructured":"Klein BE et al. (1999) Correlates of urinary symptom score in men. Am J Public Health 89: 1745\u20131748","journal-title":"Am J Public Health"},{"key":"BFncpuro0211_CR58","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0022-5347(05)67529-5","volume":"163","author":"MC Michel","year":"2000","unstructured":"Michel MC et al. (2000) Effect of diabetes on lower urinary tract symptoms in patientes with benign prostatic hyperplasia. J Urol 163: 1725\u20131729","journal-title":"J Urol"},{"key":"BFncpuro0211_CR59","first-page":"78","volume":"121","author":"RJ Glynn","year":"1985","unstructured":"Glynn RJ et al. (1985) The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 121: 78\u201390","journal-title":"Am J Epidemiol"},{"issue":"Suppl","key":"BFncpuro0211_CR60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0090-4295(91)80193-B","volume":"38","author":"S Sidney","year":"1991","unstructured":"Sidney S et al. (1991) Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology 38 (Suppl): 13\u201319","journal-title":"Urology"},{"key":"BFncpuro0211_CR61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0957-5847(03)00070-2","volume":"13","author":"C Kelleher","year":"2003","unstructured":"Kelleher C (2003) Investigation and treatment of lower urinary tract dysfunction. Curr Obstet Gynecol 13: 342\u2013349","journal-title":"Curr Obstet Gynecol"},{"issue":"Suppl 2","key":"BFncpuro0211_CR62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0090-4295(03)00605-8","volume":"62","author":"M Takeda","year":"2003","unstructured":"Takeda M et al. (2003) Diagnosis and treatment of voiding symptoms. Urology 62 (Suppl 2): 11\u201319","journal-title":"Urology"},{"key":"BFncpuro0211_CR63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s001920070041","volume":"11","author":"TP Chou","year":"2000","unstructured":"Chou TP et al. (2000) Can uroflowmetey patterns in women be reliably interpreted? Int Urogynecol J Pelvic Floor Dysfunct 11: 142\u2013147","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"BFncpuro0211_CR64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0022-5347(05)65538-3","volume":"166","author":"JL Ockrim","year":"2001","unstructured":"Ockrim JL et al. (2001) A probability based system for combining simple office parameters as a predictor of bladder outflow obstruction. J Urol 166: 221\u2013225","journal-title":"J Urol"},{"key":"BFncpuro0211_CR65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01235856","volume":"17","author":"BF Clarke","year":"1979","unstructured":"Clarke BF et al. (1979) Diabetic autonomic neuropathy. Diabetologia 17: 195\u2013212","journal-title":"Diabetologia"},{"key":"BFncpuro0211_CR66","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0022-5347(01)65209-1","volume":"157","author":"T Ueda","year":"1997","unstructured":"Ueda T et al. (1997) Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 157: 580\u2013584","journal-title":"J Urol"},{"key":"BFncpuro0211_CR67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 346: 393\u2013403","journal-title":"New Engl J Med"},{"key":"BFncpuro0211_CR68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s001920200008","volume":"13","author":"LL Subak","year":"2002","unstructured":"Subak LL et al. (2002) Does weight loss improve incontinence in moderately obese women? Int J Urogynecol J Pelvic Floor Dysfunct 13: 40\u201343","journal-title":"Int J Urogynecol J Pelvic Floor Dysfunct"},{"key":"BFncpuro0211_CR69","first-page":"775","volume-title":"Incontinence: 1st International Consultation on Incontinence","author":"AJ Wein","year":"1998","unstructured":"Wein AJ (1998) Neuromuscular dysfunction of the lower urinary tract and its treatment. Incontinence: 1st International Consultation on Incontinence, 775\u2013812 (eds Abrams P et al.) Plymouth: Health Publications"},{"key":"BFncpuro0211_CR70","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1067\/mgn.2003.49","volume":"24","author":"KF Hunter","year":"2003","unstructured":"Hunter KF and Moore KN (2003) Diabetes associated bladder dysfunction in the older adult. (CE) Geriatr Nurs 24: 138\u2013145","journal-title":"Geriatr Nurs"},{"key":"BFncpuro0211_CR71","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0022-5347(05)64682-4","volume":"168","author":"SS Yang","year":"2002","unstructured":"Yang SS et al. (2002) Alpha 1-adrenergic blockers in young men with primary bladder neck obstruction. J Urol 168: 571\u2013574","journal-title":"J Urol"},{"key":"BFncpuro0211_CR72","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00345-001-0237-0","volume":"19","author":"KE Andersson","year":"2002","unstructured":"Andersson KE (2002) Alpha-adrenoceptors and benign prostate hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists. World J Urol 19: 390\u2013396","journal-title":"World J Urol"},{"key":"BFncpuro0211_CR73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","volume":"36","author":"H Petit","year":"1998","unstructured":"Petit H et al. (1998) Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 36: 91\u201394","journal-title":"Spinal Cord"},{"key":"BFncpuro0211_CR74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0090-4295(84)90386-8","volume":"24","author":"CJ Bennett","year":"1984","unstructured":"Bennett CJ and Diokno AC (1984) Clean intermittent self-catheterization in the elderly. Urology 24: 43\u201345","journal-title":"Urology"},{"issue":"Suppl 1","key":"BFncpuro0211_CR75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0090-4295(00)00719-6","volume":"56","author":"DS Elliott","year":"2000","unstructured":"Elliott DS and Boone TB (2000) Recent advances in the management of the neurogenic bladder. Urology 56 (Suppl 1): 76\u201381","journal-title":"Urology"},{"key":"BFncpuro0211_CR76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/nau.1930140402","volume":"14","author":"H Flood","year":"1995","unstructured":"Flood H et al. (1995) Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn 14: 297\u2013309","journal-title":"Neurourol Urodyn"},{"key":"BFncpuro0211_CR77","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-5347(01)61761-0","volume":"161","author":"WW Leng","year":"1999","unstructured":"Leng WW et al. (1999) Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol 161: 758\u2013763","journal-title":"J Urol"},{"key":"BFncpuro0211_CR78","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0090-4295(00)01083-9","volume":"57","author":"T Yokoyama","year":"2001","unstructured":"Yokoyama T et al. (2001) Muscle-derived cell transfer and differentiation into lower urinary tract smooth muscle. Urology 57: 826\u2013831","journal-title":"Urology"},{"key":"BFncpuro0211_CR79","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1073\/pnas.112191399","volume":"99","author":"K Prakash","year":"2002","unstructured":"Prakash K et al. (2002) Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci USA 99: 7598\u20137603","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpuro0211_CR80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.humrep.a137317","volume":"6","author":"A Hershlag","year":"1991","unstructured":"Hershlag A et al. (1991) Retrograde ejaculation. Hum Reprod 6: 255\u2013258","journal-title":"Hum Reprod"},{"key":"BFncpuro0211_CR81","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/(SICI)1096-9136(199608)13:8<700::AID-DIA174>3.0.CO;2-8","volume":"13","author":"WD Dunsmuir","year":"1996","unstructured":"Dunsmuir WD and Holmes SA (1996) The aetiology and management of erectile, ejaculatory, and fertility problems in men with diabetes mellitus. Diabet Med 13: 700\u2013708","journal-title":"Diabet Med"},{"key":"BFncpuro0211_CR82","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0090-4295(96)00573-0","volume":"49","author":"WJ Sexton","year":"1997","unstructured":"Sexton WJ and Jarow JP (1997) Effect of diabetes mellitus upon male reproductive function. Urology 49: 508\u2013513","journal-title":"Urology"},{"key":"BFncpuro0211_CR83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.eururo.2004.07.020","volume":"46","author":"G Colpi","year":"2004","unstructured":"Colpi G et al. (2004) EAU guidelines on ejaculatory dysfunction. Eur Urol 46: 555\u2013558","journal-title":"Eur Urol"},{"key":"BFncpuro0211_CR84","unstructured":"Kamischke A and Nieschlag E (2002) Update on medical treatment of ejaculatory disorders. J Androl 333\u2013344"},{"key":"BFncpuro0211_CR85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1464-410X.1989.tb05165.x","volume":"63","author":"GE Scammell","year":"1989","unstructured":"Scammell GE et al. (1989) Retrograde ejaculation: successful treatment with artificial insemination. Br J Urol 63: 198\u2013201","journal-title":"Br J Urol"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0211","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpuro0211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:08:17Z","timestamp":1684426097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["BFncpuro0211"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0211","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}